Member Info for notrac

Hopefully it will be at a better price than the last one which was at 80p. Regret not selling more on FDA approval announcement.

I was expecting Sept for a re-rate but it looks like Q1 2023 if we are waiting on the FDA.

The agenda for the AGM is towards the end of the Annual report which you can find on the UJO website.
HL is Hargreaves Lansdown.

Those are that not yet in.

The wording suggests that there is no need for financing. Some institutions will not be pleased.

Sorry but this is normal. Look what happened to STX and FUM when they got their respective approvals. A big jump and then a slow decline until the next bit of news. Not enough institutional shareholders.

Who started this nonsense about 65% on profits? 25% maybe. Assessment for taxes on profits at 40% is only after deduction of capital allowances and losses brought forward.

And with the exchange rate at 1.226, US$ 1 million is £815K. At year-end 2021 the rate was US$ 1.35 ish (£740k). It has dropped off a cliff since April. It would be interesting to know how much of their expenses are in US$.

These have been reported in every year's financial statements since 2014. They are deferred in the event of liquidation but it doesn't specify their rights in the event of takeover or dividends. Furthermore the number was not subject to consolidation as the ordinary shares were two years ago.

When is James Barder going to pull the trigger and get a deal done, and start generating some revenue? Yet again he has blinked. What happens if FUM do not get approval from the FDA?

Agreed but usually they are obliged to keep sealed lips. Another case where the FD/CFO left while we all being told to hold on to our golden tickets was Sound Energy in the spring of 2017. I suspect there was a culture clash but it didn't look good.

No, talking but action please. Hopefully the accounts will reflect the transformation brought about by Wressle, will result in a proposal to reduce the share premium account, and then, if the share price continues to undevalue the company, allow the company to commence a buyback programme.

According to a well-known news source, it's Capital who unloaded a large holding earlier in the week.

On this day of good news for UJO, I cannot resist indulging schadenfreud as I learn that sales for one of the Sheriff's recommendations have fallen lamentably short of expectations.

It looks as though the cash generated since the Feb RNS is £550K as both the debt and the receivables mentioned last time have assumingly been cleared.

Technicals:
Today is first positive day on MACD histogram since Jan 20 2022. Yesterday's close was the first close higher than the close four trading days ago, also since Jan 20 2022. Support held at 75 over several trading days with declining volume, yesterday's vol 256K. Today's volume 1.86 million highest since Feb 2nd (sp was then 110p). Could be a coincidence.

Difficult to know whether today's uptick is due to identification of improvement in technicals (for the first time since late January) or the much waited for arrival of impending news.

@senseman
I read the article. It is clear that the writer has done no detailed research into the company.

Clearly the rumour got out at 8.00 am on March 1st. During the first hour of trading the sp dropped from 3.70p to 3.22p on quite high volume. For the same period the movement in UJO and EDR was a drop of 2%. Thereafter the rot set in as the price slid to 2.75 at close of play today. On the hourly chart, the recent run started on Feb 16th at 9.00am on Feb 16th when the price was 1.76p! EOG should have waited for a further update on Wressle.

EOG holds 30% of Wressle. However, after hours, they have announced a placing at 1.8p (50% down on Monday's close) to raise £7 million. Surprising, or perhaps not, that they couldn't wait for more good news on Wressle to get a better price. This may explain why UJO made the recent statement that they would not be raising funds in case someone picked up and disseminated false information.